Safe and Timely Antithrombotic Removal (STAR) Registry

ConditionsHemorrhage, Surgical Hemorrhage Postoperative Blood Loss, Surgical Blood Loss, Postoperative

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorCytoSorbents, Inc

About this trial

This registry will capture real-world clinical use patterns and associated clinical outcomes with the use of CytoSorb for the removal of antithrombotic agents.

Eligibility criteria

Qualifiers

CytoSorb utilization for antithrombotic removal

Informed consent for prospective registry participation

Disqualifiers

None

Trial design

Treatments tested in this trial

CytoSorb

Treatment groups

No treatment groups listed

Locations30

Select a site below to view it on the map.

Austria

Belgium

Germany

Sweden

Switzerland

United Kingdom

Sponsors and collaborators

CytoSorbents, Inc

Lead sponsor

Source ClinicalTrials.gov